Patent · US Active

Lyophilized recombinant VWF formulations

US10232022B2 · kind B2 · utility

9Cited by

32References

16Claims

0Family size

Assignee

Baxalta Incorporated · CH

Inventors

Kurt Schnecker · Wien, AT
Eva Haidweger · Wien, AT
Peter Turecek · Klosterneuburg, AT

Key dates

Filing date	Nov 12, 2015
Grant date	Mar 19, 2019
Priority date	—
Expiry date	Nov 12, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Long-term stable pharmaceutical formulations of lyophilized recombinant von-Willebrand Factor (rVWF) and methods for making and administering said formulations are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.